SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-000747
Filing Date
2022-02-14
Accepted
2022-02-14 13:51:41
Documents
55
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm   iXBRL 10-Q 637049
2 CERTIFICATION nbio_ex311.htm EX-31.1 9869
3 CERTIFICATION nbio_ex312.htm EX-31.2 9903
4 CERTIFICATION nbio_ex321.htm EX-32.1 4131
5 CERTIFICATION nbio_ex322.htm EX-32.2 4282
  Complete submission text file 0001477932-22-000747.txt   3217996

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20211231.xsd EX-101.SCH 52435
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20211231_lab.xml EX-101.LAB 250335
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20211231_cal.xml EX-101.CAL 32241
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20211231_pre.xml EX-101.PRE 200277
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20211231_def.xml EX-101.DEF 95403
49 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10q_htm.xml XML 367332
Mailing Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960
Business Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 22629114
SIC: 2834 Pharmaceutical Preparations